Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.

Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.

Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (M...

Full description

Bibliographic Details
Main Authors: Zheng Zhang, Liping Ding, Zhitao Jin, Guojie Gao, Huijun Li, Lijuan Zhang, Lina Zhang, Xin Lu, Lihua Hu, Bingwei Lu, Xiongjun Yu, Taohong Hu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4029889?pdf=render

Internet

http://europepmc.org/articles/PMC4029889?pdf=render

Similar Items